Close Menu

GlaxoSmithKline must have been feeling generous: the pharma gave $25 million to the Harvard Stem Cell Institute for a five-year partnership "to develop new methods for screening drugs with stem cells," according to this news item from Technology Review. "The time appears ripe for investing, because scientists can now use new reprogramming techniques to develop stem cells from patients with specific diseases."

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The General Data Protection Regulation has slowed some data sharing with non-European researchers as they find ways to comply with the law, ScienceInsider reports.

A bioethicist from Abertay University uses a utilitarian approach to justify genetically modifying the human germline, the BBC reports.

The US has upgraded its network of public health labs to provide whole-genome sequencing to track antibiotic-resistant bacteria, Quartz reports.

In Science this week: approach to visualize 3D genome structure in single cells, RNA interference knockdown screens to examine genetic origins of beetle horns and insect wings,  and more.